| Literature DB >> 28352324 |
Tong Qian1, Lijun Tian1, Yanyan Li1, Zhenru Zhang1, Xiuying Tian1, Dan Sun1.
Abstract
The objective of the present study was to evaluate the combined application of measuring cystatin C (Cys-C) and hemoglobin A1c (HbA1c) levels for early renal injury in pediatric patients with type 2 diabetes. A total of 130 children with type 2 diabetes admitted to our hospital from May 2013 to July 2015 were selected. Patients were divided according to whether there was complication of renal injury. In group A (n=65), the patients had renal injury and in group B (n=65), the patients did not have renal injury. The levels of Cys-C and HbA1c in the two groups were examined. The results showed that the levels of Cys-C and HbA1c of patients in group A were significantly higher than those in group B (P<0.05), and the positive rate of the combined examination of Cys-C and HbA1c in group A was 92.3%, and was higher than that of the individual examinations of either Cys-C or HbA1c (P<0.05). The Spearman's correlation coefficient analysis was applied to group B and showed that Cys-C was positively correlated with HbA1c (r=0.842, P<0.05). From analysis of the receiver operating characteristic curves, the combined examination of Cys-C and HbA1c surpassed the individual examinations of Cys-C or HbA1c in sensitivity and specificity (P<0.05). In conclusion, the positive detection rate of early renal injury was significantly increased by the combined examination of Cys-C and HbA1c in pediatric patients with type 2 diabetes, which is beneficial for early identification and diagnosis of this diseases and is worthy of clinical application.Entities:
Keywords: Cys-C; HbA1c; renal injury
Year: 2016 PMID: 28352324 PMCID: PMC5348714 DOI: 10.3892/etm.2016.3967
Source DB: PubMed Journal: Exp Ther Med ISSN: 1792-0981 Impact factor: 2.447
Comparison of general parameters of the two groups (mean ± SD).
| Gender (case) | |||||
|---|---|---|---|---|---|
| Groups | n | Male | Female | Age (years) | BMI (kg/m2) |
| Group A | 65 | 36 | 29 | 10.8±1.2 | 23.8±1.7 |
| Group B | 65 | 34 | 31 | 10.3±0.9 | 24.1±1.9 |
| P-value | >0.05 | >0.05 | >0.05 | >0.05 | |
Figure 1.Concentration of cystatin C (Cys-C) in the two groups. **P<0.05 compared to that of group B.
Figure 2.Level of hemoglobin A1c (HbA1c) in the two groups. **P<0.05 compared to that of group B.
Comparisons of the positive rate of combined examination of Cys-C and HbA1c and the individual examinations of the patients in group A.
| Classification | n | Positive | Negative | Positive rate (%) |
|---|---|---|---|---|
| Individual examination of Cys-C | 65 | 47 | 18 | 72.3 |
| Individual examination of HbA1c | 65 | 50 | 15 | 76.9 |
| Combined examination of Cys-C and HbA1c | 65 | 60 | 5 | 92.3 |
| P-value | <0.05 |
Cys-C, cystatin C; HbA1c, hemoglobin A1c.
Figure 3.Correlation analysis of cystatin C (Cys-C) with hemoglobin A1c (HbA1c).
Figure 4.Receiver operating characteristic (ROC) curve of cystatin C (Cys-C), hemoglobin A1c (HbA1c) and a combination of Cys-C and HbA1c.